Patients Coming Off Weight-Loss Medications Gain Back Weight Four Times Faster Than Those on Conventional Diets

New research indicates that patients who stop using blockbuster slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise regimens.

Findings released in a prominent medical journal points out that while overweight individuals can lose substantial amounts of their body weight while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.

"People purchasing such medications must be aware of the risk of rapid weight regain when the medication concludes," stated researcher Dr. Susan Jebb.

That rate of recovery means a reversion to starting mass within about a year and a half.

Comparing Therapies

The study, which examined 37 of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with other pills.

Scientists note that people who shed pounds through diet and exercise usually have a more gradual weight regain—approximately 100 grams monthly—after stopping.

Understanding the Quick Rebound

Doctors propose the mechanism of the drugs accounts for the amplified weight return.

The injections copy a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of GLP-1 levels far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.

"Stopping of this medication leads to appetite is no longer kept in check, making binge eating a significant risk."

A Chronic Issue?

The NHS advise the injections for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.

Professionals contend that, considering the high risk of weight regain, the treatment should be considered long-term.

This perspective is supported by drug manufacturers, who say that the findings "highlight the chronic character of obesity," akin to managing conditions like diabetes.

Patient Experiences

Users who have discontinued the medication describe a sudden resurgence of hunger.

"It felt as if a switch that goes on and I was suddenly starving," described an individual.

This difficulty is exacerbated if patients have not adopted lasting lifestyle or habit changes during therapy.

Widespread Adoption

Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.

• Adoption is greater among women than men.
• The middle-aged age group shows the highest usage rates.
• Many access the medications through private healthcare rather than the NHS.

In conclusion, researchers caution that while the jabs are effective tools for shedding pounds, they are not a standalone fix and maintained weight loss hinges on integrated behavioural management.